Want to buy for someone else? You can purchase a token at check out.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
The goal of this program is to provide information about the incidence, etiology, identification, and care of the late-preterm infant.
Goals and Outcomes
Goals and Learning Outcomes
The group of infants categorized as “late-preterm” are a growing public health concern. Although they may look like term newborns in appearance and weight, they have a greater risk for respiratory problems, temperature instability, hyperbilirubinemia, hypoglycemia, infection, apnea, feeding difficulties, breastfeeding failure, poor neurodevelopmental outcomes, and rehospitalization. In 2005, the National Institutes of Health recommended calling infants born between 34 0/7 weeks and 36 6/7 weeks “late-preterm” instead of near-term infants because their increased physiologic and metabolic immaturity reflected higher morbidity and mortality, and their special needs are often closer to those of premature infants. This course provides nurses with information about the incidence, etiology, identification, and care of late-preterm infants. The goal of this educational program is to provide information about the incidence, etiology, identification, and care of late-preterm infants.

After taking this course, you should be able to:

  • Define “late-preterm infant” and explain why this designation is a better description than “near-term infant”
  • Describe three common problems of the late-preterm infant
  • Identify four nursing interventions in the care and discharge planning for this group of infants
  • Define “late-preterm infant” and explain why this designation is a better description than “near-term infant.”
  • Describe at least three common problems of the late pre-term infant.
  • Identify at least four nursing interventions for care and discharge planning for this group of infants.

Course Termination Date: 08/05/23

Content Expiration Date: 07/31/23

Course Originally Released On: 09/01/20
Details
Course Details

Course Originally Released on : 9/1/2020

REL-ACU-0-LPICET

Course Author

Patricia H. White

MSN-Ed, RNC-NIC, CNE

Laura Bell

BSN, RN, CCRN

Melissa M. Dunham

RN, MSN, ARNP, NNP-BC

Michele J. Beaulieu

APRN, DNP, NNP-BC

Janice C. White

RN, MA

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.